Literature DB >> 12011586

Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter.

Jo C Tsai1, Jie Zhang, Takashi Minami, Carole Voland, Shuping Zhao, Xianjin Yi, Philippe Lassalle, Peter Oettgen, William C Aird.   

Abstract

Endothelial-cell-specific molecule-1 (ESM-1) is a cysteine-rich protein that is expressed primarily in endothelial cells of the lung, kidney and gut. In the present study, we have cloned and sequenced 3,888 bp of the 5' flanking region of the human ESM-1 gene. The full-length promoter directed high-level expression of the luciferase reporter gene in bovine lung microvascular endothelial cells and bovine aortic endothelial cells, but not in nonendothelial cell types. In 5' deletion analyses, a region spanning -81 to +58 was shown to contain information for endothelial-cell-specific expression. Mutational analysis in transient transfection assays uncovered an important role for an Ets-binding motif located between -77 and -74 and a cAMP-response-element (CRE)-like motif located between -68 and -62 in mediating high-level expression in endothelial cells. A second Ets site (-63 to -60) as well as a novel 6-bp palindromic sequence (-58 to -53) were found to inhibit expression. In DNase footprint analyses, both the Ets-binding motifs were protected specifically in endothelial cells, while the CRE-like element and palindrome were protected in endothelial and nonendothelial cells alike. Taken together, these results provide an important foundation for studying endothelial-cell-subtype-specific gene regulation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011586     DOI: 10.1159/000057763

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  14 in total

1.  Endocan: A new marker for cancer and a target for cancer therapy.

Authors:  Jinghui Yang; Qiwei Yang; Shan Yu; Xuewen Zhang
Journal:  Biomed Rep       Date:  2015-02-26

2.  DNA motifs in human and mouse proximal promoters predict tissue-specific expression.

Authors:  Andrew D Smith; Pavel Sumazin; Zhenyu Xuan; Michael Q Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

3.  Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.

Authors:  Lei Yuan; Vesna Nikolova-Krstevski; Yumei Zhan; Maiko Kondo; Manoj Bhasin; Laya Varghese; Kiichiro Yano; Chris V Carman; William C Aird; Peter Oettgen
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

4.  The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis.

Authors:  Fatma Zehra Kadayıfçı; Makbule Gezmen Karadağ
Journal:  Eur J Rheumatol       Date:  2018-03

5.  Endocan, a Soluble Marker of Endothelial Cell Activation Is a Molecular Marker of Disease Severity in Women with Preeclampsia.

Authors:  Sarah N Cross; Irina A Buhimschi; Christina Duzyj Buniak; Lydia Shook; Megan McCarthy; John Hardy; Yara El-Helou; Guomao Zhao; Catalin S Buhimschi
Journal:  Reprod Sci       Date:  2022-02-03       Impact factor: 2.924

Review 6.  Endocan: a novel circulating proteoglycan.

Authors:  Arunava Kali; K S Rathan Shetty
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

7.  ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells.

Authors:  Juan Rebollo; Jan Geliebter; Niradiz Reyes
Journal:  Int J Biomed Sci       Date:  2017-03

8.  Identification of ESM1 overexpressed in head and neck squamous cell carcinoma.

Authors:  Hongbo Xu; Xiaohong Chen; Zhigang Huang
Journal:  Cancer Cell Int       Date:  2019-05-02       Impact factor: 5.722

9.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28

10.  Loss of Endocan tumorigenic properties after alternative splicing of exon 2.

Authors:  Florence Depontieu; Bogdan-Dragos Grigoriu; Arnaud Scherpereel; Estelle Adam; Maryse Delehedde; Philippe Gosset; Philippe Lassalle
Journal:  BMC Cancer       Date:  2008-01-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.